This topic contains a solution. Click here to go to the answer

Author Question: The nurse explains that for stability of the IV insertion site in an infant younger than 9 months of ... (Read 73 times)

melly21297

  • Hero Member
  • *****
  • Posts: 565
The nurse explains that for stability of the IV insertion site in an infant younger than 9 months of age, the insertion site is the:
 
  a. radial vein.
  b. scalp vein.
  c. femoral vein.
  d. brachial vein.

Question 2

The nurse preparing to administer an IM injection to a 2-year-old recognizes the preferred injection site for a child of this age is the:
 
  a. deltoid muscle.
  b. upper thigh.
  c. mid-thigh.
  d. gluteus.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

choc0chan

  • Sr. Member
  • ****
  • Posts: 362
Answer to Question 1

B
A superficial scalp vein is the injection site for administering IV medication to infants younger than 9 months of age.

Answer to Question 2

C
The primary site for an IM injection for a 2-year-old is the vastus lateralis.




melly21297

  • Member
  • Posts: 565
Reply 2 on: Jul 11, 2018
Excellent


mochi09

  • Member
  • Posts: 335
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Warfarin was developed as a consequence of the study of a strange bleeding disorder that suddenly occurred in cattle on the northern prairies of the United States in the early 1900s.

Did you know?

The senior population grows every year. Seniors older than 65 years of age now comprise more than 13% of the total population. However, women outlive men. In the 85-and-over age group, there are only 45 men to every 100 women.

Did you know?

Cytomegalovirus affects nearly the same amount of newborns every year as Down syndrome.

Did you know?

The first oncogene was discovered in 1970 and was termed SRC (pronounced "SARK").

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library